The influence of biomechanical parameters on the expression of VEGF and endostatin in the bone and joint system

Annals of Anatomy

Volumn 187, Issue 5-6, 2005, Pages 461-472

  Pufe, Thomas ^a   Kurz, Bodo ^a   Petersen, Wolf ^b   Varoga, Deike ^c   Mentlein, Rolf ^a   Kulow, Svea ^a   Lemke, Angelika ^a   Tillmann, Bernhard ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Endostatin; Osteoarthristis; Spontaneous tendon rupture; Vascular endothelial growth factor; VEGF

Indexed keywords

ENDOSTATIN; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSCRIPTION FACTOR AP 1; VASCULOTROPIN;

ARTICLE; ARTICULAR CARTILAGE; BIOMECHANICS; BONE ATROPHY; BONE DISEASE; CARTILAGE CELL; ENZYME PHOSPHORYLATION; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; MECHANICAL STRESS; MOLECULAR MECHANICS; OSTEOARTHRITIS; PATHOLOGICAL ANATOMY; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; TENDON DISEASE;

EID: 28344439308     PISSN: 09409602     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.aanat.2005.06.008     Document Type: Article

References (66)

1. Alfredson, H., Thorsen, K., Lorentzon, R., 1999. In situ microdialysis in tendon tissue: high levels of glutamate, but not prostaglandin E2 in chronic Achilles tendon pain. Knee Surg. Sports Traumatol. Arthrosc. 7, 378-381.
2. Alfredson, H., Forsgren, S., Fahlltröm, M., Johannson, M., Thorsen, K., Lorentzon, R., 2001. Glutamate NMDAR1 receptors locaLised to nerves in human Achilles tendons. Implications for treatment. Knee Surg. Sports Traumatol. Arthrosc. 9, 334-338.
3. Alfredson, H., Bjur, D., Thorsen, K., Lorentzon, R., Sandstrom, P., 2002. High intratendinous lactate levels in painful chronic Achilles tendinosis. An investigation using microdialysis technique. J. Orthop. Res. 20, 934-938.
4. Alfredson, H., Ohberg, L., Forsgren, S., 2003. Is vasculoneural in growth the cause of pain in chronic Achilles tendinosis? An investigation using ultrasonography and colour Doppler, immunohistochemistry, and diagnostic injections. Knee Surg. Sports Traumatol. Arthrosc. 11, 334-338.
5. Altmann, K., 1964. Zur kausalen Histiogenese des Knorpels. W. Roux's Theorie und experimentelle Wirklichkeit. Z. Anat. Entwickl. Gesch. 37, 1-167.
6. Astrom, M., Westlin, N., 1994. Blood flow in the human Achilles tendon assessed by laser Doppler flowmetry. J. Orthop. Res. 12, 246-252.
7. Bullough, P.G., Jagannath, 1983. The morphology of the calcification front in articular cartilage. Its significance in joint function. J. Bone Joint. Surg. Br. 65, 72-78.
8. Durr, J., Lammi, P., Goodman, S.L., Aigner, T., von der Mark, K., 1996. Identification and immunolocalization of laminin in cartilage. Exp. Cell. Res. 222, 225-233.
9. Enomoto, H., Inoki, I., Komiya, K., Shiomi, T., Ikeda, E., Obata, K., Matsumoto, H., Toyama, Y., Okada, Y., 2003. Vascular endothelial growth factor isoforms and their receptors are expressed in human osteoarthritic cartilage. Am. J. Pathol. 162, 171-181.
10. Fava, R.A., Olsen, N.J., Spencer-Green, G., Yeo, K.T., Yeo, T.K., Berse, B., Jackman, R.W., Senger, D.R., Dvorak, H.F., Brown, L.F., 1994. Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J. Exp. Med. 180, 341-346.
11. Ferrara, N., 1999. Molecular and biological properties of vascular endothelial growth factor. J. Mol. Med. 77, 527-543.
12. Forstreuter, F., Lucius, R., Mentlein, R., 2002. Vascular endothelial growth factor induces chemotaxis and proliferation of microglial cells. J. Neuroimmunol. 132, 93-98.
13. Fukai, N., Eklund, L., Marneros, A.G., Oh, S.P., Keene, D.R., Tamarkin, L., Niemela, M., Ilves, M., Li, E., Pihlajaniemi, T, Olsen, B., 2002. Lack of colLagen XVII/endostatin results in eye abnormalities. EMBO J. 21, 1535-1544.
14. Furumatsu, T., Yamaguchi, N., Nishida, K., Kawai, A., Kunisada, T., Namba, M., Inoue, H., Ninomiya, Y., 2002. Endostatin inhibits adhesion of endothelial cells to collagen I via alpha(2)beta(1) integrin, a possible cause of prevention of chondrosarcoma growth. J. Biochem. (Tokyo) 131, 619-626.
15. Gerber, H.R, Vu, TH., Ryan, A.M., Kowalski, J., Werb, Z., Ferrara, N., 1999. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat. Med. 5, 623-628.
16. Good, D.J., Polverini, P.J., Rastinejad, F., Le Beau, M.M., Lemons, R.S., Frazier, W.A., Bouck, N.R, 1990. A tumor suppressor inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc. Natl. Acad. Sci. USA 87, 6624-6628.
17. Halfter, W., Dong, S., Schurer, B., Cole, G.J., 1998. Collagen XVIII is a basement membrane heparan sulfate proteoglycan. J. Biol. Chem. 273, 25404-25412.
18. Hashimoto, S., Creighton-Achermann, L., Takahashi, K., Amiel, D., Coutts, R.D., Lotz, M., 2002. Development and regulation of osteophyte formation during experimental osteoarthritis. Osteoarthritis Cartilage 10, 180-187.
19. Hayes, A.J., Benjamin, M., Ralphs, J.R., 2001. Extracellular matrix in development of the intervertebral disc. Matrix Biol. 20, 107-121.
20. Honorati, M.C., Cattini, L., Facchini, A., 2004. IL-17, IL-1beta and TNF-alpha stimulate VEGF production by dedifferentiated chondrocytes. Osteoarthritis Cartilage 12, 683-691.
21. Josko, J., Mazurek, M., 2004. Transcription factors having impact on vascular endothelial growth factor (VEGF) gene expression in angiogenesis. Med. Sci. Monit. 10, 89-98.
22. Jozsa, L.G., Kannus, P., 1997. Human Tendons - Anatomy, Physiology and Pathology. Human Kineticy, Champain, IL USA.
23. Karumanchi, S.A., Jha, V., Ramchandran, R., Karihaloo, A., Tsiokas, L., Chan, B., Dhanabal, M., Hanai, J.I., Venkataraman, G., Shriver, Z., Keiser, N., Kalluri, R., Zeng, H., Mukhopadhyay, D., Chen, R.L., Lander, A.D., Hagihara, K., Yamaguchi, Y., Sasisekharan, R., Cantley, L., Sukhatme, V.P., 2001. Cell surface glypicans are low-affinity endostatin receptors. Mol. Cell. 7, 811-822.
24. Kim, Y.M., Jang, J.W., Lee, O.H., Yeon, J., Choi, E.Y., Kim, K.W., Lee, S.T., Kwon, Y.G., 2000. Endostatin inhibits endothelial and tumor cellular invasion by blocking the activation and catalytic activity of matrix metalloproteinase. Cancer Res. 60, 5410-5413.
25. Kim, Y.M., Hwang, S., Kim, Y.M., Pyun, B.J., Kim, T.Y., Lee, S.T., Gho, Y.S., Kwon, Y.G., 2002. Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1. J. Biol. Chem. 277, 27872-27879.
26. Krishnan, L., Song, H., Hoying, J.B., Das, R., Weiss, J.A., 2003. Angiogenesis alters the material properties of the extracellular matrix. Transactions of the Orthopaedic Research Society: 278.
27. Li, J., Hampton, T., Morgan, J.P., Simons, M., 1997. Stretch-induced VEGF expression in the heart. J. Clin. Invest. 100, 18-24.
28. Liu, N., Lapcevich, R.K., Underhill, C.B., Han, Z., Gao, F., Swart, G., Plum, S., Zhang, L., Green, S.J., 2001. Metastatin: a hyaluronan-binding complex from cartilage inhibits tumor growth. Cancer Res. 61, 1022-1028.
29. Maffulli, N., Testa, V., Capasso, G., Ewen, S.W., Sullo, A., Benazzo, F., King, J.B., 2004. Similar histopathological picture in males with Achilles and patellar tendinopathy. Med. Sci. Sports. Exerc. 36, 1470-1475.
30. Mayr-Wohlfart, U., Waltenberger, J., Hausser, H., Kessler, S., Gunther, K.P., Dehio, C., Puhl, W., Brenner, R.E., 2002. Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts. Bone 30, 472-477.
31. Mentlein, R., Held-Feindt, J., 2003. Angiogenesis factors in gliomas - a new key to tumour therapy? Naturwissenschaften 90, 385-394.
32. Miosge, N., Simniok, T., Sprysch, P., Herken, R., 2003. The collagen type XVIII enclostatin domain is colocalized with perlecan in basement membranes in vivo. J. Histochem. Cytochem. 51, 285-296.
33. Moses, M.A., Wiedeschain, D., Wu, I., Fernandez, C., Ghazizadh Lane, W.S., Flynn, E., Sytkowski, A., Tao, T., Langer, R., 1999. Troponin I is present in human cartilage and inhibits angiogenesis. Proc. Natl. Acad. Sci. 96, 2645-2650.
34. Movin, T, Gad, A., Reinholt, F.P., Rolf, C., 1997. Tendon pathology in long-standing achillodynia. Biopsy findings in 40 patients. Acta. Orthop. Scand. 68, 170-175.
35. Neufeld, G., Cohen, T., Genginovitch, S., Poltrak, Z., 1999. Vascular endothelial growth factor and its receptors. FASEB J. 13, 9-22.
36. Ohberg, L., Alfredson, H., 2003. Sclerosing therapy in chronic Achilles tendon insertional pain-results of a pilot study. Knee Surg. Sports. Traumatol. Arthrosc. 11, 339-343.
37. Ohberg, L., Lorentzon, R., Alfredsn, H., 2001. Neovascularisation in Achilles tendons with painful tendinosis but not in normal tendons: an ultrasonographic investigation. Knee Surg. Sports. Traumatol. Arthrosc. 9, 235-238.
38. O'Reilly, M.S., Behm, T, Sing, Y., Fikai, N., Vasios, G., Lane, W.S., Flynn, E., Birkhead, J.R., Olsen, B.R., Folkman, J., 1997. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88, 277-285.
39. Pauwels, F., 1960. A new theory on the influence of mechanical stimuli on the differentiation of supporting tissue. The tenth contribution to the functional anatomy and causal morphology of the supporting structure. Z. Anat. Entwicklungsgsesch. 121, 478-515 German; in English language part of Pauwels, 1980.
40. Petersen, W., Tillmann, B., 1995. Age-related blood and lymph supply of the knee menisci. A cadaver study. Acta Orthop. Scand. 66, 308-312.
41. Petersen, W., Tillmann, B., 1999. Structure and vascularization of the knee joint menisci. Z. Orthop. Ihre Grenzgeb. 137, 31-37.
42. Petersen, W., Pufe, T., Kurz, B., Mentlein, R., Tillmann, B., 2002a. Angiogenesis in fetal tendon development: spatial and temporal expression of the angiogenetic peptide vascular endothelial growth factor (VEGF). Anat. Embryol. 205, 263-270.
43. Petersen, W., Tsokos, M., Pufe, T., 2002b. Expression of VEGF121 and VEGF165 in hypertrophic chondrocytes of the human growth plate and epiphyseal cartilage. J. Anat. 201, 153-157.
44. Petersen, W., Unterhauser, F., Pufe, T., Zantop, T., Sudkamp, N.P., Weiler, A., 2003. The angiogenic peptide vascular endothelial growth factor (VEGF) is expressed during the remodeling of free tendon grafts in sheep. Arch. Orthop. Trauma. Surg. 123, 168-174.
45. Petersen, W., Varoga, D., Zantop, T., Hassenpflug, J., Mentlein, R., Pufe, T., 2004a. Cyclic strain influences the expression of the vascular endothelial growth factor (VEGF) and the hypoxia inducible factor 1 alpha (HIF-1α) in tendon fibroblasts. J. Orthop. Res. 22, 847-853.
46. Petersen, W., Pufe, T., Zantop, T., Tillmann, B., Tsokos, M., Mentlein, R., 2004b. Expression of VEGFR-1 and VEGFR-2 in degenerative Achilles tendons. Clin. Orthop. 420, 286-291.
47. Pfander, D., Kortje, D., Zimmermann, R., Weseloh, G., Kirsch, T., Gesslein, M., Cramer, T, Swoboda, B., 2001. Vascular endothelial growth factor in articular cartilage of healthy and osteoarthritic human knee joints. Ann. Rheum. Dis. 60, 1070-1073.
48. Pufe, T., Petersen, W., Tillmann, B., Mentlein, R., 2001a. Expression of the vascular endothelial growth factor in osteoarthritic cartilage. Arthritis Rheum. 44, 1082-1088.
49. Pufe, T., Petersen, W., Tillmann, B., Mentlein, R., 2001b. The angiogenic peptide vascular endothetial cell growth factor (VEGF) is expressed in fetal and ruptured tendons. Virchows Arch. 439, 579-585.
50. Pufe, T., Wildemann, B., Petersen, W., Mentlein, R., Raschke, M., Schmidmaier, G., 2002. Quantitative measurement of the splice variants 120 and 164 of the angiogenic peptide vascular endothelial growth factor (VEGF) in the time flow of fracture heating: a study in rat. Cell Tissue Res. 309, 387-392.
51. Pufe, T., Petersen, W., Kurz, B., Tsokos, M., Tillmann, B., Mentlein, R., 2003a. Mechanical factors influence the expression of endostatin - an inhibitor of angiogenesis - in tendons. J Orthop. Res. 21, 610-616.
52. Pufe, T., Paulsen, F., Petersen, W., Mentlein, R., Tsokos, M., 2003b. The angiogenic peptide vascular endothelial growth factor (VEGF) is expressed in chronic sacral pressure ulcers. J. Pathol. 200, 130-136.
53. Pufe, T., Scholz-Ahrens, K.E., Franke, A.T.M., Petersen, W., Mentlein, R., Varoga, D., Tillmann, B., Schrezenmeir, J., Glüer, C.C., 2003c. The role of VEGF (vascular endothelial growth factor) in glucocorticoid induced bone loss: evaluation in a minipig model. Bone 33, 869-876.
54. Pufe, T., Lemke, A., Kurz, B., Petersen, W., Tillmann, B., Menttein, R., 2004a. Mechanical overload induces VEGF in cartilage explants via hypoxia-inducible factor (HIF). Am. J. Pathol. 164, 185-192.
55. Pufe, T., Harde, V., Petersen, W., Goldring, M.B., Tillmann, B., Mentlein, R., 2004b. VEGF induces matrix metalloprotease expression in chondrocytes. J. Pathol. 202, 367-374.
56. Pufe, T, Petersen, W., Goldring, M.B., Mentlein, R., Varoga, D., Tsokos, M., Tillmann, B., 2004c. Endostatin - an inhibitor of angiogenesis - is expressed in human cartilage and fibrocartitage. Matrix Biol 23, 267-276.
57. Qi, J.H., Ebrahem, Q., Moore, N., Murphy, G., Claesson-Welsh, L., Bond, M., Baker, A., Anand-Apte, B., 2003. A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2. Nat. Med. 9, 407-415.
58. Safran, M.R., 1995. Elbow injuries in athletes. A review. Clin. Orthop., 257-277.
59. Sato, Y., Abe, M., Tanaka, K., Iwasaka, C., Oda, N., Kanno, S., Oikawa, M., Nakano, T, Igarashi, T., 2000. Signal transduction and transcriptional regulation of angiogenesis. Adv. Exp. Med. Biot. 476, 109-115.
60. Senger, D.R., Gatti, S.J., Dvorak, A.M., Perruzzi, C.A., Harvey, V.S., Dvorak, H.F., 1983. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid 25, 983-985.
61. Smith, J.O., Oreffo, R.O., Clarke, N.M., Roach, H.I., 2003. Changes in the antiangiogenic properties of articular cartilage in osteoarthritis. J. Orthop. Sci. 8, 849-857.
62. Street, J., Bao, M., deGuzman, L., Bunting, S., Peale Jr, F.V., Ferrara, N., Steinmetz, H., Hoeffel, J., Cleland, J.L., Daugherty, A., van Bruggen, N., Redmond, H.P., Carano, R.A., Filvaroff, E.H., 2002. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc. Natl. Acad. Sci. USA 99, 9656-9661.
63. Studer, R., Jaffurs, D., Stefanovic-Racic, M., Robbins, P.D., Evans, C.H., 1999. Nitric oxide in osteoarthritis. Osteoarthritis Cartilage 7, 377-379.
64. Takahashi, K., Saishin, Y., Saishin, Y., Silva, R.L., Oshima, Y., Oshima, S., Melia, M., Paszkiet, B., Zerby, D., Kadan, M.J., Liau, G., Kaleko, M., Connelly, S., Luo, T., Campochiaro, RA., 2003. Intraocular expression of endostatin reduces VEGF-induced retinal vascular permeability, neovascularization, and retinal detachment. FASEB J. 17, 896-898.
65. Wang, H., Keiser, J.A., 1998. Vascular endothetial growth factor upregutates the expression of matrix metallo-proteinases in vascular smooth muscle cells: role of flt-1. Circ. Res. 83, 832-840.
66. Westermarck, J., Kahari, V.M., 1999. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 13, 781-792.